Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535944) titled 'Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors' on April 10.
Study Type: Observational
Primary Sponsor: University Hospital, Rouen
Condition:
Vascular Complications
Intervention:
Other: Evaluation of the vascular impact of ICIs (Immune Checkpoint Inhibitors)
Recruitment Status: Not recruiting
Date of First Enrollment: June 1, 2026
Target Sample Size: 200
To know more, visit https://clinicaltrials.gov/study/NCT07535944
Disclaimer: Curated by HT Syndication....